Loading clinical trials...
Loading clinical trials...
An Observational Phase IV Non Interventional Study in Patients With Advanced Follicular Lymphoma (III-IV) Evaluating the Safety of Maintenance Therapy With Rituximab After 8 Cycles of Rituximab in Combination With Chemotherapy as Induction Therapy in Previously Untreated Patients in Greece.
Conditions
Locations
4
Greece
Athens, Greece
Athens, Greece
Pátrai, Greece
Thessaloniki, Greece
Start Date
October 1, 2012
Primary Completion Date
November 1, 2012
Completion Date
November 1, 2012
Last Updated
November 2, 2016
NCT06785818
NCT04911478
NCT06425302
NCT02278796
NCT00081809
NCT02376699
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions